Allergic Rhinitis Clinical Trials

Find Allergic Rhinitis Clinical Trials Near You

Validation of an Allergic Rhinitis Control Test in Children

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 11
Healthy Volunteers: f
View:

• Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis

• Parents formulated their study participation agreement by signing the consent form.

Locations
Other Locations
France
CH Louis Pasteur
COMPLETED
Bagnols-sur-cèze
Maison de santé de Lasalle
TERMINATED
Lasalle
CH de MILLAU
COMPLETED
Millau
Centre (Ctre) Medical Ravas - Malbosc
COMPLETED
Montpellier
University hospital of Montpellier
RECRUITING
Montpellier
Hôpital Trousseau,
COMPLETED
Paris
Contact Information
Primary
Pascal DEMOLY, Professor
pascal.demoly@inserm.fr
+334 67 33 61 27
Backup
Anca CHIRIAC, MD
a-chiriac@chu-montpellier.fr
Time Frame
Start Date: 2017-05-04
Estimated Completion Date: 2027-07
Participants
Target number of participants: 135
Treatments
Experimental: Experimental
questionnaire for allergic rhinitis control children from 5 to 11 years old who complete a self questionnaire regarding allergic rhinitis control during the consultation and after 15 days
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov